Experiment: 2MXW

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308
2	3D 1H-13C NOESY aliphatic	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308
3	3D 1H-13C NOESY aromatic	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308
4	3D 1H-15N NOESY	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308
5	APSY 4D-HACANH	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308
6	APSY 5D-CBCACONH	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308
7	APSY 5D-HACACONH	1.2 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium chloride, 20 mM sodium phosphate, 5 mM sodium azide, 90% H2O, 10% D2O	90% H2O/10% D2O	0.240	6.0	ambient	308

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
torsion angle dynamics	SEMI-AUTOMATED STRUCTURE DETERMINATION WITH THE J-UNIO SUITE	UNIO

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	80
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	peak picking	UNIO	v2010	Hermann and Wuthrich
2	chemical shift assignment	CARA		Keller and Wuthrich
3	refinement	CYANA	3.0	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.